Skip to Content
Palsonify Logo

Now FDA Approved

Palsonify Logo

Now FDA Approved

GO TO PALSONIFY.COM

Investigator-Initiated Study Process & Application

By submitting an application you are not guaranteed the approval of the funding request.
Crinetics Pharmaceuticals follows a thorough review process and will approve or deny requests at its sole discretion.
Crinetics may provide support for an IIS through a grant of funding, product, or both.

If an investigator or institution desires funding and/or free product for research to be initiated, conducted, and sponsored,
a complete IIS grant request must be submitted through the IIS portal (see below). Please contact us at
[email protected] with any questions.

IIS Process

  1. Proposal Submission: All IIS proposals must be submitted through the IIS Portal with required documentation for review by our Scientific Review Committee (SRC).
  2. Review & Approval: A cross-functional SRC evaluates each proposal for scientific merit, relevance, and funding availability. A final study protocol is not required at initial submission but is required before any grant is provided.
  3. Agreement: Before the start of an IIS, a legal agreement detailing study details and milestones must be completed and fully executed.
  4. Disbursement: Payments and/or provision of investigational drugs are made per the agreed-upon milestones in the executed contract, with final payment upon study completion and submission of final deliverables.

Funding will not be provided for:

  • Individuals
  • Fellowships
  • Overhead and general operating expenses
  • Entertainment, including meals
  • Awards
  • Travel

 

Investigator-Initiated Study Application


To begin your application please review the terms below and provide your consent below: